upa retatrutide Obesity is expected to affect nearly a quarter of the world population by 2035. Retatrutide, an investigational GIP, GLP-1, and GCG receptor agonist, holds promise for weight reduction in adults. New Medscape | Retatrutide, Eli Lilly's

Disclaimer: Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease

Research & Development purposes only.

Retatrutide causes predominantly gastrointestinal side effects (nausea, vomiting, diarrhea, constipation) that are dose-dependent and mostly mild-to-moderate...

Custom capsule formula discussion, white bottle packaging, low MOQ, documentation and launch support.

At The Vitamin Shoppe, we are proud to be a destination for health & wellness, and to continue to evolve with our customers' needs by now offering access to GLP-1 Rx medicationsincluding Ozempic, Rybelsus, Mounjaro, and compound semaglutide and tirzepatide formulasthrough Whole Health Rx by The Vitamin Shoppe

GLP-1 receptor agonist medications have become one of the fastest-growing pharmaceutical trends in the United States, with millions of patients now using these compounds for weight management and metabolic health